Octave Specialty Group Q2'26 Revenue Jumps 77%
Total revenues surged 51% to $83 million and adjusted EBITDA tripled vs expectations driven by the ArmadaCare acquisition, despite net losses, as ongoing operations stabilize.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day